has been cited by the following article(s):
[1]
|
Antibody persistence in children aged 6–7 years one year following booster immunization with two MMR vaccines applied by aerosol or by injection
Vaccine,
2017
DOI:10.1016/j.vaccine.2017.04.027
|
|
|
[2]
|
Prevalencia de anticuerpos frente a parotiditis en niños y adolescentes a dos años de haberse introducido la vacuna SRP
Salud Pública de México,
2017
DOI:10.21149/8138
|
|
|
[3]
|
Relevant Facts from Aerosol Measles Vaccine Studies
World Journal of Vaccines,
2016
DOI:10.4236/wjv.2016.63006
|
|
|
[4]
|
The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update
Translational Respiratory Medicine,
2014
DOI:10.1186/2213-0802-2-3
|
|
|
[5]
|
Booster immune response in children 6–7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection
Vaccine,
2014
DOI:10.1016/j.vaccine.2014.04.031
|
|
|
[6]
|
Safety and immunogenicity of dry powder measles vaccine administered by inhalation: A randomized controlled Phase I clinical trial
Vaccine,
2014
DOI:10.1016/j.vaccine.2014.09.071
|
|
|